BDI Customer Service
(800) 948-9834
On-Call 24 / 7 for emergency
and after hours ordering
|
Press Release and Industry News
| ATryn Available for Patients with Hereditary
Antithrombin Deficiency, a Rare Blood Clotting Disorder |
| May 6, 2009 – Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN:
Copenhagen Stock Exchange), announced today that ATryn® (Antithrombin [Recombinant]) is
now available in the United States. In February 2009, the U.S. Food and Drug Administration
(FDA) granted marketing approval of ATryn,
Read More |
| Posted: June 11, 2009 |
|
| |
| Kogenate FS |
| Bayer Healthcare proudly
announces an important milestone in its commitment to protecting the
joint health of patients living with Hemophilia A. Read
More. |
| Posted October 14, 2008 |
|
| Grifols Launches PediGri® On Line for its US
Plasma Therapies |
| Today, Grifols launched
in the US its proprietary PediGri® On Line system that gives
healthcare providers access to quality and safety information
about the plasma used in the production of Grifols' therapies.
Read More |
| Posted: October 2, 2008 |
|
| CSL Behring's Innovative HeliTraxSM System
Helps Physicians Manage Hemophilia A Patients Wireless Device
Provides Comprehensive Picture, Improves Patient-Physician
Communications |
| Hemophilia A patients who use
Helixate® FS, Antihemophilic Factor (Recombinant), and their
treatment providers are now tracking treatment progress in real
time, thanks to the HeliTraxSM System, a state-ot-the-art wireless
internet-based data management system recently introduced by CSL
Behring.
Read More |
| Posted: September 5, 2008 |
|
| Grifols Announces FDA Approval of Alphanate to
treat von Willebrand Disease |
| Delivering on a promise to the
bleeding disorders community, Grifols offers the only dual
inactivated and US manufactured, antihemophilic factor/von
Willebrand factor complex .
Read More |
| |
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
|